Venker Eric — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Venker Eric has filed 4 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $103.31M.

Profile

Eric Venker is a prominent executive in the biopharmaceutical industry, currently serving as the President and CEO of Immunovant, Inc. He has held various leadership roles at Roivant Sciences Ltd. and its subsidiaries, focusing on advancing innovative healthcare solutions.

Board memberships

• Roivant Sciences Ltd.
• Immunovant, Inc.

Awards & honors

• Leadership in biopharmaceutical innovation
• Development of novel therapies
• Executive roles in multiple healthcare companies

Recent Transactions

Companies — Last 90 Days

• Immunovant, Inc. (IMVT) — 1 filings, last 2026-07-06
• Roivant Sciences Ltd. (ROIV) — 3 filings, last 2026-06-26

Frequently Asked Questions

Who is Venker Eric?

Eric Venker is a prominent executive in the biopharmaceutical industry, currently serving as the President and CEO of Immunovant, Inc. He has held various leadership roles at Roivant Sciences Ltd. and its subsidiaries, focusing on advancing innovative healthcare solutions.…

How many SEC Form 4 filings has Venker Eric submitted recently?

4 primary Form 4 filings in the last 90 days, covering 2 companies.

Has Venker Eric been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 31 open-market sales ($103.31M) across all tracked filings.

Where can I see all of Venker Eric's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week